Skip to main content
. 2016 May 8;2016(5):CD010529. doi: 10.1002/14651858.CD010529.pub2

Comparison 14. Triethylenethiophophoramide.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Pleurodesis failure 1   Odds Ratio (M‐H, Random, 95% CI) Subtotals only
1.1 Triethylene... vs placebo 1 24 Odds Ratio (M‐H, Random, 95% CI) 0.34 [0.03, 3.69]
1.2 Triethylene... vs mepacrine 1 29 Odds Ratio (M‐H, Random, 95% CI) 4.95 [1.02, 24.10]
2 Pain 1 53 Odds Ratio (M‐H, Random, 95% CI) 1.39 [0.10, 20.15]
2.1 Triethylene... vs mepacrine 1 29 Odds Ratio (M‐H, Random, 95% CI) 0.48 [0.10, 2.30]
2.2 Triethylene... vs placebo 1 24 Odds Ratio (M‐H, Random, 95% CI) 7.43 [0.35, 156.28]
3 Fever 1 53 Odds Ratio (M‐H, Random, 95% CI) 0.32 [0.00, 26.74]
3.1 Triethylene... vs placebo 1 24 Odds Ratio (M‐H, Random, 95% CI) 3.52 [0.15, 81.92]
3.2 Triethylene... vs mepacrine 1 29 Odds Ratio (M‐H, Random, 95% CI) 0.04 [0.01, 0.30]